Etsuro Matsubara

This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Immunas Pharma, Inc., National Center for Geriatrics and Gerontology. Active years: 2013-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Etsuro Matsubara. Retrieved from https://idiyas.com/inventor/etsuro-matsubara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)

Company Filing History:

National Center for Geriatrics and Gerontology

patents

where one patent can have more than one assignee

Years Active: 2013-2015

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9090680 - Antibodies that specifically bind to abeta oligomers and uses thereof (2015-07-28),

2. 9085614 - Antibodies that specifically bind to Aβ oligomers and uses thereof (2015-07-21),

3. 8378081 - Antibodies that specifically bind to Aβ oligomers and uses thereof (2013-02-19),

Title: Etsuro Matsubara: Innovator in Alzheimer's Disease Research

Introduction

Etsuro Matsubara is a prominent inventor based in Aomori, Japan. He has made significant contributions to the field of Alzheimer's disease research through his innovative work in monoclonal antibodies. With a total of 3 patents, Matsubara's inventions focus on the development of diagnostic and therapeutic tools for this debilitating condition.

Latest Patents

Matsubara's latest patents include groundbreaking work on antibodies that specifically bind to Aβ oligomers. These monoclonal antibodies are designed to recognize only soluble Aβ oligomers while avoiding soluble Aβ monomers, which are physiological molecules. This specificity demonstrates their potential utility as diagnostic and therapeutic agents for Alzheimer's disease.

Career Highlights

Throughout his career, Etsuro Matsubara has worked with notable organizations such as Immunas Pharma, Inc. and the National Center for Geriatrics and Gerontology. His research has been pivotal in advancing our understanding of Alzheimer's disease and developing effective treatments.

Collaborations

Matsubara has collaborated with esteemed colleagues, including Masao Shibata and Tatsuki Yokoseki. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Etsuro Matsubara's work in the field of Alzheimer's disease research exemplifies the impact of innovation in medicine. His patents and collaborations highlight the importance of targeted therapies in addressing complex health challenges.

Profile summary based on public USPTO records.